1087 related articles for article (PubMed ID: 8755652)
21. Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts.
van Kesteren CA; van Heugten HA; Lamers JM; Saxena PR; Schalekamp MA; Danser AH
J Mol Cell Cardiol; 1997 Aug; 29(8):2147-57. PubMed ID: 9281446
[TBL] [Abstract][Full Text] [Related]
22. Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR.
Touyz RM; Endemann D; He G; Li JS; Schiffrin EL
Hypertension; 1999 Jan; 33(1 Pt 2):366-72. PubMed ID: 9931131
[TBL] [Abstract][Full Text] [Related]
23. Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.
Gorbea-Oppliger VJ; Melaragno MG; Potter GS; Petit RL; Fink GD
J Pharmacol Exp Ther; 1994 Nov; 271(2):804-10. PubMed ID: 7965799
[TBL] [Abstract][Full Text] [Related]
24. AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature.
Muller C; Endlich K; Barthelmebs M; Helwig JJ
Br J Pharmacol; 1997 Dec; 122(7):1495-501. PubMed ID: 9421301
[TBL] [Abstract][Full Text] [Related]
25. Role of angiotensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders.
Fyhrquist F; Metsärinne K; Tikkanen I
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S19-24. PubMed ID: 8583476
[TBL] [Abstract][Full Text] [Related]
26. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
Uhlenius N; Vuolteenaho O; Tikkanen I
J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
[TBL] [Abstract][Full Text] [Related]
27. Characterization of glomerular angiotensin II receptor subtypes.
Gauquelin G; Garcia R
Receptor; 1992; 2(3):207-12. PubMed ID: 1472951
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin II-1 receptors mediate both vasoconstrictor and hypertrophic responses in rat aortic smooth muscle cells.
Chiu AT; Roscoe WA; McCall DE; Timmermans PB
Receptor; 1991; 1(3):133-40. PubMed ID: 1843203
[TBL] [Abstract][Full Text] [Related]
29. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.
Stoll M; Steckelings UM; Paul M; Bottari SP; Metzger R; Unger T
J Clin Invest; 1995 Feb; 95(2):651-7. PubMed ID: 7860748
[TBL] [Abstract][Full Text] [Related]
30. Acute myocardial and vascular responses to specific angiotensin II antagonism in the spontaneously hypertensive rat.
Cody RJ; Binkley PF; Haas GJ; Brown DM
Am J Hypertens; 1995 May; 8(5 Pt 1):500-8. PubMed ID: 7662227
[TBL] [Abstract][Full Text] [Related]
31. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet.
Ruan X; Wagner C; Chatziantoniou C; Kurtz A; Arendshorst WJ
J Clin Invest; 1997 Mar; 99(5):1072-81. PubMed ID: 9062366
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation.
Lassègue B; Alexander RW; Nickenig G; Clark M; Murphy TJ; Griendling KK
Mol Pharmacol; 1995 Oct; 48(4):601-9. PubMed ID: 7476884
[TBL] [Abstract][Full Text] [Related]
33. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model].
Ponchon P; Elghozi JL
Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874
[TBL] [Abstract][Full Text] [Related]
34. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism.
Gohlke P; Pees C; Unger T
Hypertension; 1998 Jan; 31(1 Pt 2):349-55. PubMed ID: 9453327
[TBL] [Abstract][Full Text] [Related]
35. Functional roles of brain AT1 and AT2 receptors in the central angiotensin II pressor response in conscious young spontaneously hypertensive rats.
Toney GM; Porter JP
Brain Res Dev Brain Res; 1993 Feb; 71(2):193-9. PubMed ID: 8491041
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular effects after the intracerebroventricular administration of peptide and nonpeptide angiotensin antagonists in Dahl salt-sensitive rats.
Lark LA; Wappel SM; Weyhenmeyer JA
J Pharmacol Exp Ther; 1995 Aug; 274(2):745-51. PubMed ID: 7636738
[TBL] [Abstract][Full Text] [Related]
37. New perspectives in angiotensin system control.
Timmermans PB; Wong PC; Chiu AT; Herblin WF; Smith RD
J Hum Hypertens; 1993 Aug; 7 Suppl 2():S19-31. PubMed ID: 8230085
[TBL] [Abstract][Full Text] [Related]
38. Diphenylpropionic acids as new AT1 selective angiotensin II antagonists.
Almansa C; Gómez LA; Cavalcanti FL; de Arriba AF; Rodríguez R; Carceller E; García-Rafanell J; Forn J
J Med Chem; 1996 May; 39(11):2197-206. PubMed ID: 8667363
[TBL] [Abstract][Full Text] [Related]
39. A new class of therapeutic agents: the angiotensin II receptor antagonists.
Timmermans PB; Smith RD
Cardiologia; 1994 Dec; 39(12 Suppl 1):397-400. PubMed ID: 7634303
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade.
Jones ES; Black MJ; Widdop RE
J Mol Cell Cardiol; 2004 Nov; 37(5):1023-30. PubMed ID: 15522279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
